Screening of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spectrometry

Clinical Chemistry

Volumn 52, Issue 9, 2006, Pages 1735-1742

  Sauvage, François Ludovic ^a   Saint Marcoux, Franck ^a   Duretz, Bénédicte ^b   Deporte, Didier ^b   Lachatre, Gérard ^a,c   Marquet, Pierre ^a,c  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

^b MDS SCIEX   (Canada)

^c UNIVERSITY OF LIMOGES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALIMEMAZINE; AMIODARONE; AMISULPRIDE; ATENOLOL; CARBAMAZEPINE; CLOZAPINE; DEXTROPROPOXYPHENE; DIAZEPAM; FLECAINIDE; GLAFENINE; IMIPRAMINE; LIDOCAINE; LORAZEPAM; METOCLOPRAMIDE; MIANSERIN; MOCLOBEMIDE; NANDROLONE; NORDAZEPAM; OMEPRAZOLE; PARACETAMOL; PRIMIDONE; PROCAINAMIDE; QUINIDINE; QUININE; RANITIDINE; RITONAVIR; THEOPHYLLINE; TIAPRIDE; UNINDEXED DRUG; VENLAFAXINE;

ARTICLE; DRUG SCREENING; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; REVERSED PHASE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

ANTIPSYCHOTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FORENSIC MEDICINE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GASTROINTESTINAL CONTENTS; HUMANS; PHARMACEUTICAL PREPARATIONS; SOFTWARE; SOLUTIONS; XENOBIOTICS;

EID: 33748316481     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.067116     Document Type: Article

References (18)

1. Marquet P. Is LC-MS suitable for a comprehensive screening of drugs and poisons in clinical toxicology? Ther Drug Monit 2002;24:125-33.
2. Marquet P. Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Ther Drug Monit 2002;24:255-76.
3. Maurer HH. Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology. Clin Biochem 2005;38:310-8.
4. Saint-Marcoux F, Lachâtre G, Marquet P. Evaluation of an improved general unknown screening procedure using liquid chromatography-electrospray- mass spectrometry by comparison with gas chromatography and high-performance liquid-chromatography-diode array detection. J Am Soc Mass Spectrom 2003;14:14-22.
5. Venisse N, Marquet P, Duchoslav E, Dupuy JL, Lachâtre G. A general unknown screening procedure for drugs and toxic compounds in serum using liquid chromatography-electrospray-single quadrupole mass spectrometry. J Anal Toxicol 2003;27:7-14.
6. Decaestecker TN, Clauwaert KM, Van Bocxlaer JF, Lambert WE, Van den Eeckhout EG, Van Peteghem CH, et al. Evaluation of automated single mass spectrometry to tandem mass spectrometry function switching for comprehensive drug profiling analysis using a quadrupole time-of-flight mass spectrometer. Rapid Commun Mass Spectrom 2000;14:1787-92.
7. Fitzgerald RL, Rivera JD, Herold DA. Broad spectrum drug identification directly from urine, using liquid chromatography-tandem mass spectrometry. Clin Chem 1999;45:1224-34.
8. Decaestecker TN, Van de Casteele SR, Wallemacq PE, Van Peteghem CH, Defore DL, Van Bocxlaer JF. Information-dependent acquisition-mediated LC-MS/MS screening procedure with semi-quantitative potential. Anal Chem 2004;76:6365-73.
9. Mueller CA, Weinmann W, Dresen S, Schreiber A, Gergov M. Development of a multi-target screening analysis for 301 drugs using a QTrap liquid chromatography/tandem mass spectrometry system and automated library searching. Rapid Commun Mass Spectrom 2005;19:1332-8.
10. Marquet P, Saint-Marcoux F, Gamble TN, Leblanc JC. Comparison of a preliminary procedure for the general unknown screening of drugs and toxic compounds using a quadrupole-linear ion-trap mass spectrometer with a liquid chromatography-mass spectrometry reference technique. J Chromatogr B Analyt Technol Biomed Life Sci 2003;789:9-18.
11. Hager JW, Leblanc JC. High-performance liquid chromatography-tandem mass spectrometry with a new quadrupole/linear ion trap instrument. J Chromatogr A 2003;1020:3-9.
12. Jansen R, Lachâtre G, Marquet P. LC-MS/MS systematic toxicological analysis: comparison of MS/MS spectra obtained with different instruments and settings. Clin Biochem 2005;38:362-72.
13. Leblanc JC, Bloomfield N. Dynamic background subtraction to improve candidate ion selection for information dependent acquisition LC-MSMS analysis. 52nd American Society for Mass Spectrometry Proceedings, June 1-4, 2004, Nashville, TN.
14. Flanagan RJ. Guidelines for the interpretation of analytical toxicology results and unit of measurement conversion factors. Ann Clin Biochem 1998;35:261-7.
15. Decaestecker TN, Coopman EM, Van Peteghem CH, Van Bocxlaer JF. Suitability testing of commercial solid-phase extraction sorbents for sample clean-up in systematic toxicological analysis using liquid chromatography- (tandem) mass spectrometry. J Chromatogr B 2003;789:19-25.
16. Decaestecker TN, Lambert WE, Van Peteghem CH, Deforce DL, Van Bocxlaer JF. Optimization of solid-phase extraction for a liquid chromatographic-tandem mass spectrometric general unknown screening procedure by means of computational techniques. J Chromatogr A 2004;1056:57-65.
17. Sauvage FL, Gaulier JM, Lachâtre G, Marquet P. A fully automated turbulent-flow liquid chromatography-tandem mass spectrometry technique for monitoring antidepressants in human serum. Ther Drug Monit 2006;28:123-30.
18. Krouwer JS, Rabinowitz R. How to improve estimates of imprecision. Clin Chem 1984;30:290-2.